Development of dendritic cell loaded MAGE-A2 long peptide; a potential target for tumor-specific T cell-mediated prostate cancer immunotherapy.
Cancer Cell Int
; 23(1): 270, 2023 Nov 11.
Article
de En
| MEDLINE
| ID: mdl-37951911
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Langue:
En
Journal:
Cancer Cell Int
Année:
2023
Type de document:
Article
Pays d'affiliation:
Iran